Found: 18
Select item for more details and to access through your institution.
Efficacy and Safety of Upadacitinib vs Dupilumab in Adults With Moderate-to-Severe Atopic Dermatitis: A Randomized Clinical Trial.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Early and Sustained Improvements in Symptoms and Quality of Life with Upadacitinib in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis: 52-Week Results from Two Phase III Randomized Clinical Trials (Measure Up 1 and Measure Up 2)
- Published in:
- American Journal of Clinical Dermatology, 2024, v. 25, n. 3, p. 485, doi. 10.1007/s40257-024-00853-4
- By:
- Publication type:
- Article
Baseline Characteristics from UNITE: An Observational, International, Multicentre Registry to Evaluate Hidradenitis Suppurativa (Acne Inversa) in Clinical Practice.
- Published in:
- American Journal of Clinical Dermatology, 2020, v. 21, n. 4, p. 579, doi. 10.1007/s40257-020-00504-4
- By:
- Publication type:
- Article
Comparative Efficacy of Targeted Systemic Therapies for Moderate-to-Severe Atopic Dermatitis without Topical Corticosteroids: An Updated Network Meta-analysis.
- Published in:
- Dermatology & Therapy, 2023, v. 13, n. 10, p. 2247, doi. 10.1007/s13555-023-01000-3
- By:
- Publication type:
- Article
Safety and Efficacy of Upadacitinib for Atopic Dermatitis in Japan: 2-Year Interim Results from the Phase 3 Rising Up Study.
- Published in:
- Dermatology & Therapy, 2023, v. 13, n. 1, p. 221, doi. 10.1007/s13555-022-00842-7
- By:
- Publication type:
- Article
Comparative Efficacy of Targeted Systemic Therapies for Moderate to Severe Atopic Dermatitis without Topical Corticosteroids: Systematic Review and Network Meta-analysis.
- Published in:
- Dermatology & Therapy, 2022, v. 12, n. 5, p. 1181, doi. 10.1007/s13555-022-00721-1
- By:
- Publication type:
- Article
Comparative efficacy of targeted systemic therapies with topical corticosteroids for moderate-to-severe atopic dermatitis: an updated network meta-analysis.
- Published in:
- British Journal of Dermatology, 2024, v. 190, p. ii19, doi. 10.1093/bjd/ljad498.023
- By:
- Publication type:
- Article
Efficacy and safety of upadacitinib through 140 weeks in adolescents and adults with moderate-to-severe atopic dermatitis: phase 3 randomized clinical trial results.
- Published in:
- British Journal of Dermatology, 2024, v. 190, p. ii8, doi. 10.1093/bjd/ljad498.010
- By:
- Publication type:
- Article
427 Long-term 4-year safety of upadacitinib in moderate-to-severe atopic dermatitis: results of an integrated analysis of phase 3 studies.
- Published in:
- British Journal of Dermatology, 2023, v. 188, p. 1, doi. 10.1093/bjd/ljad162.047
- By:
- Publication type:
- Article
413 Improvement in itch, symptoms and quality of life with upadacitinib through week 16 in adults and adolescents with atopic dermatitis: results from phase 3 studies (Measure Up 1, Measure Up 2 and AD Up).
- Published in:
- British Journal of Dermatology, 2023, v. 188, p. 1, doi. 10.1093/bjd/ljad162.033
- By:
- Publication type:
- Article
393 Comparative efficacy of targeted systemic therapies for moderate-to-severe atopic dermatitis without topical corticosteroids: an updated network meta-analysis.
- Published in:
- British Journal of Dermatology, 2023, v. 188, p. 1, doi. 10.1093/bjd/ljad162.018
- By:
- Publication type:
- Article
Population pharmacokinetic and exposure‐response modelling to inform upadacitinib dose selection in adolescent and adult patients with atopic dermatitis.
- Published in:
- British Journal of Clinical Pharmacology, 2023, v. 89, n. 10, p. 3139, doi. 10.1111/bcp.15803
- By:
- Publication type:
- Article
Biologics in the Treatment of Psoriasis: Clinical and Economic Overview.
- Published in:
- Journal of Cutaneous Medicine & Surgery, 2009, v. 13, p. S49, doi. 10.2310/7750.2009.00021
- By:
- Publication type:
- Article
Achieving Hidradenitis Suppurativa Response Score is Associated with Significant Improvement in Clinical and Patient-reported Outcomes: Post Hoc Analysis of Pooled Data From PIONEER I and II.
- Published in:
- Acta Dermato-Venereologica, 2018, v. 98, n. 10, p. 932, doi. 10.2340/00015555-3012
- By:
- Publication type:
- Article
Real‐world clinical, psychosocial and economic burden of atopic dermatitis: Results from a multicountry study.
- Published in:
- Journal of the European Academy of Dermatology & Venereology, 2024, v. 38, n. 2, p. 340, doi. 10.1111/jdv.19500
- By:
- Publication type:
- Article
Upadacitinib treatment withdrawal and retreatment in patients with moderate‐to‐severe atopic dermatitis: Results from a phase 2b, randomized, controlled trial.
- Published in:
- Journal of the European Academy of Dermatology & Venereology, 2023, v. 37, n. 12, p. 2558, doi. 10.1111/jdv.19391
- By:
- Publication type:
- Article
Adalimumab treatment optimization for psoriasis: Results of a long-term phase 2/3 Japanese study.
- Published in:
- Journal of Dermatology, 2015, v. 42, n. 11, p. 1042, doi. 10.1111/1346-8138.13001
- By:
- Publication type:
- Article
Exposure‐Response Analyses for Upadacitinib Efficacy in Subjects With Atopic Dermatitis—Analyses of Phase 2b Study to Support Selection of Phase 3 Doses.
- Published in:
- Journal of Clinical Pharmacology, 2021, v. 61, n. 5, p. 628, doi. 10.1002/jcph.1782
- By:
- Publication type:
- Article